The innovative device, which is the size and shape of a grain of rice, can perform hundreds of studies at the same time to examine the impact of novel treatments on some of the most difficult-to-treat brain tumours.
Researchers from Brigham and Women's Hospital, a founding member of the Mas
For the first time, researchers discovered a potential drug candidate that improved outcomes for patients suffering from a type of childhood brain tumour that has no effective treatment. When compared to previous patients, the compound, called ONC201, nearly doubled survival for patients wit
Scientists have developed an AI tool that can instantly decode a brain tumour's DNA to determine its molecular identification during surgery - vital information that can take a few days to a few weeks under the present approach.
Scientists have developed an AI tool that can rapidly decode a brain tumour's DNA to determine its molecular identity during surgery, critical information that can take a few days to a few weeks under the current approach.
Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to identify folate receptors in brain tumours. The identification of folate receptors and its potential application in brain tumours is a fresh and significant scientific breakthrough.
According to a new research has discovered that people with a common kind of benign brain tumour diagnosed in about 1 in 10 need not need yearly scans.
To detect folate receptors in brain tumours, folate-based radiopharmaceuticals can be utilised in positron emission tomography (PET) imaging. The identification of folate receptors and their possible application in brain tumours is a novel and major development in the science.
Chennai (Tamil Nadu) [India], June 9: Kauvery Hospital, Radial Road, in observance of World Brain Tumour Day on June 8th, organized a special event for the Brain Tumour Support Group - Connect. The event brought together patients and their families to share their experiences and organised ev
A new targeted therapy medicine can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening, according to an international trial co-led by UCLA. The discovery provides a potential new therapeutic option for those suffering from the slow-growi